2 completed. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Profasi: new trials by email Literature Review of Profasi trials Research Report on Profasi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS hCG - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | UConn Health | 89 | 2013-03-01 | 2018-10-26 |
| A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET) r-hCG, Urinary-hCG - Infertility | Phase 3 | Completed | Merck KGaA, Darmstadt, Germany | 218 | 2003-12-01 | 2014-07-31 |
Helping Behavior (1) · Infertility (1) · Ovarian Hyperstimulation Syndrome (1) · Polycystic Ovary Syndrome (1)
Merck KGaA, Darmstadt, Germany (1) · UConn Health (1)
China (1) · United States (1)
Huafei Li (1) · Lawrence Engmann, MD (1)